253 related articles for article (PubMed ID: 19681875)
1. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument.
Frew JW; Martin LK; Nijsten T; Murrell DF
Br J Dermatol; 2009 Dec; 161(6):1323-30. PubMed ID: 19681875
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with epidermolysis bullosa.
Tabolli S; Sampogna F; Di Pietro C; Paradisi A; Uras C; Zotti P; Castiglia D; Zambruno G; Abeni D
Br J Dermatol; 2009 Oct; 161(4):869-77. PubMed ID: 19624546
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch population.
Yuen WY; Frew JW; Veerman K; van den Heuvel ER; Murrell DF; Jonkman MF
Acta Derm Venereol; 2014 Jul; 94(4):442-7. PubMed ID: 24337132
[TBL] [Abstract][Full Text] [Related]
4. Quality of life measurements in epidermolysis bullosa: tools for clinical research and patient care.
Frew JW; Murrell DF
Dermatol Clin; 2010 Jan; 28(1):185-90. PubMed ID: 19945634
[TBL] [Abstract][Full Text] [Related]
5. Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study.
Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R
Indian J Dermatol Venereol Leprol; 2022; 88(2):177-183. PubMed ID: 34491666
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.
Chan Y; Ching JY; Cheung CM; Tsoi KK; Polder-Verkiel S; Pang SH; Quan WL; Kee KM; Chan FK; Sung JJ; Wu JC
Aliment Pharmacol Ther; 2010 Feb; 31(3):452-60. PubMed ID: 19878152
[TBL] [Abstract][Full Text] [Related]
7. Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).
Loh CC; Kim J; Su JC; Daniel BS; Venugopal SS; Rhodes LM; Intong LR; Law MG; Murrell DF
J Am Acad Dermatol; 2014 Jan; 70(1):89-97.e1-13. PubMed ID: 24355263
[TBL] [Abstract][Full Text] [Related]
8. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.
Basra MK; Sue-Ho R; Finlay AY
Br J Dermatol; 2007 Mar; 156(3):528-38. PubMed ID: 17300244
[TBL] [Abstract][Full Text] [Related]
9. Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese.
Cestari T; Prati C; Menegon DB; Prado Oliveira ZN; Machado MC; Dumet J; Nakano J; Murrell DF
Int J Dermatol; 2016 Feb; 55(2):e94-9. PubMed ID: 26474322
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of an Asthma-Specific Quality of Life (A-QOL) questionnaire.
Lee EH; Kim SH; Choi JH; Jee YK; Nahm DH; Park HS
J Asthma; 2009 Sep; 46(7):716-21. PubMed ID: 19728212
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and patient-based hearing status in conductive hearing loss.
Stewart MG
Laryngoscope; 2001 Nov; 111(11 Pt 2 Suppl 98):1-21. PubMed ID: 11802001
[TBL] [Abstract][Full Text] [Related]
12. Development of the BD-QoL: a quality of life measure specific to Behçet's disease.
Gilworth G; Chamberlain MA; Bhakta B; Haskard D; Silman A; Tennant A
J Rheumatol; 2004 May; 31(5):931-7. PubMed ID: 15124253
[TBL] [Abstract][Full Text] [Related]
13. A pilot quality-of-life instrument for pruritus.
Desai NS; Poindexter GB; Monthrope YM; Bendeck SE; Swerlick RA; Chen SC
J Am Acad Dermatol; 2008 Aug; 59(2):234-44. PubMed ID: 18550210
[TBL] [Abstract][Full Text] [Related]
14. Quality of life instrument for Turkish people with skin diseases.
Gurel MS; Yanik M; Simsek Z; Kati M; Karaman A
Int J Dermatol; 2005 Nov; 44(11):933-8. PubMed ID: 16336527
[TBL] [Abstract][Full Text] [Related]
15. VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis.
Kahn SR; Lamping DL; Ducruet T; Arsenault L; Miron MJ; Roussin A; Desmarais S; Joyal F; Kassis J; Solymoss S; Desjardins L; Johri M; Shrier I;
J Clin Epidemiol; 2006 Oct; 59(10):1049-56. PubMed ID: 16980144
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an epidermolysis bullosa family/parental burden score.
Dufresne H; Hadj-Rabia S; Taieb C; Bodemer C
Br J Dermatol; 2015 Dec; 173(6):1405-10. PubMed ID: 26281012
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of the fecal incontinence and constipation quality of life measure in children with spina bifida.
Nanigian DK; Nguyen T; Tanaka ST; Cambio A; DiGrande A; Kurzrock EA
J Urol; 2008 Oct; 180(4 Suppl):1770-3; discussion 1773. PubMed ID: 18721959
[TBL] [Abstract][Full Text] [Related]
18. Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure.
Salamon G; Strobl S; Field-Werners U; Diem A; Schwieger-Briel A; Pope E
Br J Dermatol; 2024 Jun; 191(1):75-81. PubMed ID: 38261404
[TBL] [Abstract][Full Text] [Related]
19. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL).
Leong KP; Kong KO; Thong BY; Koh ET; Lian TY; Teh CL; Cheng YK; Chng HH; Badsha H; Law WG; Lau TC; Chew LC; Ho HJ; Pong LY; Hoi LS; Sangeetha N; Chan SP; Howe HS
Rheumatology (Oxford); 2005 Oct; 44(10):1267-76. PubMed ID: 15797980
[TBL] [Abstract][Full Text] [Related]
20. The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.
Cavanna AE; Schrag A; Morley D; Orth M; Robertson MM; Joyce E; Critchley HD; Selai C
Neurology; 2008 Oct; 71(18):1410-6. PubMed ID: 18955683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
